Kinfo
Bio-Rad Laboratories, Inc. logo

Bio-Rad Laboratories, Inc.

BIO.BNYSEHealthcare·US · USD
$337.00
+0.00 (+0.00%)
Prices as of August 10, 2026 · live

Price

Key statistics

Valuation
Market cap9.01B USD
Enterprise value8.76B USD
Trailing P/E41.00
Forward P/E0.00
PEG ratio2.16
Price / sales3.48
Price / book1.26
Profitability
Gross margin53.12%
Operating margin11.18%
Profit margin8.59%
Return on assets1.66%
Return on equity3.11%
Income (TTM)
Revenue2.59B USD
Gross profit1.35B USD
EBITDA482.70M USD
Net income222.40M USD
Diluted EPS$8.22
Rev. growth (YoY)-0.10%
Balance sheet
Total cash1.62B USD
Total debt1.37B USD
Debt / equity19.10
Current ratio3.14
Book value / share$268.30
Cash flow (TTM)
Operating cash flow492.60M USD
Levered free cash flow283.19M USD
Shares & price
Shares outstanding26.74M
Float20.54M
Held by institutions0.08%
Beta1.05
50-day MA$307.45
200-day MA$296.00
52-week high$337.00
52-week low$244.54
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-02-190.740.78+5.41%2026-01-170.380.34−10.53%2025-11-260.56-0.62−210.71%2020-07-291.221.61+31.97%2020-05-051.571.91+21.66%
About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. is a leading developer and manufacturer of advanced analytical and diagnostic technologies, playing a pivotal role in the life sciences and clinical diagnostics sectors. With a history dating back to 1952, Bio-Rad specializes in creating innovative products that develop precise and reliable solutions for laboratories worldwide. The company provides tools and systems that are instrumental in a wide range of applications, including genomics, proteomics, and food safety, thereby serving industries such as healthcare, research institutions, and quality testing. Bio-Rad's offerings include PCR instruments, chromatography systems, and immunoassays, supporting both research and clinical diagnostic processes. The company’s commitment to pioneering reliable scientific advancements has firmly positioned it in the global market as a trusted partner in scientific exploration and healthcare enhancement.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Norman D. Schwartz
Employees
7,450
Headquarters
Hercules, CA, United States

Frequently asked questions about Bio-Rad Laboratories, Inc.